Where does Vynt rank among its competitors?

Vynt ranks 10th amongst 11 active competitors, of which 4 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Collate, which secured $95M in Jun, 2026.

Who are the top competitors of Vynt?

Vynt's top competitors include Weave, Artos and Collate. Among them, Collate secured the most recent funding round in June, 2026.

Vynt - 2026 Company Profile & Competitors

Company Details

Developer of advisory intelligence software for regulated life sciences documentation. This software assists teams by strengthening the planning, drafting, and pre-submission readiness of materials. It provides decision support through explainable logic and source-linked evidence rather than performing automated approvals or replacing formal review processes. The system integrates into workflows to improve documentation clarity and reduce rework before assets enter review systems. All recommendations remain subject to human verification and judgment to maintain regulatory compliance.

Key Metrics

Stage

Unfunded

Ranked

10^th among 11 active competitors

Similar Companies

Knowledgeable & 2 more

View Vynt's full profile

Vynt has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Vynt include Weave, Artos and Collate. Here is the list of Top 10 competitors of Vynt, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Weave 2022, New Haven (United States), Series A	AI-powered platform to accelerate investigational new drug submission	$36M	Innovation Endeavors, USVP & 3 others	61/100
2nd	Artos 2023, San Francisco (United States), Seed	Provider of document-drafting platform for life sciences companies	$500K	Y Combinator, NVO Capital	38/100
3rd	Collate United States, Series C	Developer of an AI platform streamlining paperwork for life science companies	$125M	Redpoint Ventures, First Round Capital & 2 others	36/100
4th	Ritivel 2025, San Francisco (United States), Seed	Developer of an AI regulatory platform for life sciences submissions	$500K	Y Combinator	31/100
5th	X Doc 2021, Singapore (Singapore), Unfunded	Platform offering document management solutions	-	-	24/100
6th	RegHero 2024, San Francisco (United States), Unfunded	AI powered regulatory compliance platform for medical devices	-	-	22/100
7th	Pure Monograph Vancouver (Canada), Unfunded	Developer of artificial intelligence software for drug design and formulation	-	-	16/100
8th	Knowledgeable 2023, United States, Unfunded	Developer of an artificial intelligence platform for market access teams	-	-	16/100
9th	Crowe 2018, Phoenix (United States), Unfunded	Developer of documentation tools for regulatory controlled substance registration applications	-	-	16/100
10th	Vynt Unfunded	Developer of advisory intelligence software for regulated life sciences documentation	-	-	16/100